Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer terminated NMIBC trial due to strategic consideration

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Dec 22, 2022 2:46pm

180 Views

Post# 35187757

RE:RE:RE:RE:RE:Pfizer terminated NMIBC trial due to strategic consideration

ScienceFirst wrote: PlanTrader ... That was theoretical example. As only a nes release can confirm something real.

SF, I meant with some hypothetical #s in it as far as what it would mean to TLT overall. And moving forward. I know it's pure speculation; probably makes it a silly question.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market